XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Identify scenarios where active funds may outperform, focusing on market environments, fees, and your risk tolerance.
14,457 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
As job cuts persist in early 2026, employers cite AI adoption to explain restructuring. The trend underscores why wor...
Federal Reserve Governor Michael S. Barr outlined three AI-driven labor-market futures, including a worst-case jobles...
Rhythmic secures a $4 million seed round led by Dragonfly to embed stablecoins into consumer-brand ecosystems, pairin...
CubeSmart sits in a crowded self-storage field. This guide breaks down the key indicators I watch to assess whether C...
As investors await gatx (gatx) 2025 earnings, this guide breaks down what to watch in the quarterly results, how the ...
Two dividend stocks double right now can help steady your income while you grow wealth. We break down two dependable ...
Affluent homeowners are shaping the remodeling outlook as 2026 approaches. Aging housing stock and increased equity b...
Is a recession priced into market? This guide breaks down what pricing in expectations really means, the data to watc...
In 2025, Marathon Petroleum delivered a powerful cash-return story for shareholders. This article breaks down how the...
The Mexican army killed cartel chief El Mencho in a late Sunday operation, prompting airlines to suspend flights to P...
Ethereum co-founder Vitalik Buterin escalated ETH sales as prices retreat. On-chain data show 1,869 ETH sold for abou...